(1 - 16 von 18
)
Trials Take on Permanent- vs. Biodegradable-Polymer Technology |...
www.tctmd.com
trial, Tom Adriaenssens, MD, of University Hospital Leuven (Leuven, Belgium),
and colleagues randomized 64 ACS patients—21 STEMI, 21 NSTEMI, and 22
stable/unstable angina—with de novo lesions in a 1:1 ratio to ...
sortiert nach Relevanz / Datum